Subscribe

Risk Factors for Posttransplant Lymphoproliferative Disorder (PTLD) in a Renal Transplant Patient Treated with Belatacept (Nulojix)

Specialty:

Hematology Oncology

Objective:

ICD-10:

Description:

Belatacept (Nulojix) is a selective T-cell co-stimulation blocker that is used to prevent rejection in renal transplant patients. It is associated with a number of potentially serious complications, one of which is a posttransplant lymphoproliferative disorder (PTLD).

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone